| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 31.707 | 42.383 | 22.844 | 32.546 | 30.721 | 30.931 | - |
| Total Income - EUR | - | - | - | 31.707 | 49.694 | 22.844 | 32.546 | 53.654 | 30.931 | - |
| Total Expenses - EUR | - | - | - | 2.075 | 7.339 | 6.632 | 8.631 | 10.354 | 25.131 | - |
| Gross Profit/Loss - EUR | - | - | - | 29.632 | 42.355 | 16.212 | 23.915 | 43.301 | 5.800 | - |
| Net Profit/Loss - EUR | - | - | - | 28.681 | 40.864 | 15.564 | 22.958 | 42.262 | 5.497 | - |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 1 | - |
Check the financial reports for the company - Opticlue-Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 47.177 | 51.642 | 49.459 | 40.878 | 34.105 | 26.440 | - |
| Current Assets | - | - | - | 105.126 | 91.666 | 107.084 | 76.101 | 62.260 | 74.970 | - |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Receivables | - | - | - | 67.673 | 71.256 | 69.905 | 53.458 | 51.596 | 51.439 | - |
| Cash | - | - | - | 37.453 | 20.410 | 37.179 | 22.644 | 10.664 | 23.530 | - |
| Shareholders Funds | - | - | - | 122.073 | 127.300 | 140.451 | 100.115 | 78.653 | 83.911 | - |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | - |
| Debts | - | - | - | 30.230 | 16.008 | 16.092 | 16.864 | 17.712 | 17.499 | - |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Opticlue-Med Srl